Current Protein & Peptide Science

Wenzheng Bao received his Ph.D in computer science from Tongji University in 2018. He received the master degree in computer science from the University of Jinan in 2015. He currently works for school of information and electrical engineering, Xuzhou University of Technology, Xuzhou, China. His research interests include bioinformatics, machine learning, computational biology and proteomics.

Dr Martiniano Bello Ramírez obtained BSc. Biological Pharmaceutical Chemistry, from the University of Veracruz (2003), MSc. Biochemical Sciences, National Autonomous University of Mexico (2006), and Ph. D. Biochemical Sciences, National Autonomous University of Mexico (2010). Currently, he is a Research Professor at the Superior School of Medicine of National Polytechnic Institute of Mexico. He has published more than 50 articles in well-reputed journals. Besides, he is a reviewer of many journals such as European Journal of Medical Chemistry, Pharmaceuticals, Journal of Molecular Modeling, PlosOne, Plos Computational Biology, Proteins: Structure, Function, and Bioinformatics, Molecular BioSystems, Physical Chemistry Chemical Physics, Open Chemistry, Anti-Cancer Agents in Medicinal Chemistry and many more.

Dr. Feng Guang Gao is presently serving as an Associate Professor, Department of Basic Medicine, Medical College, Xiamen University, China. He completed his Masters of Science from Medical School, Shandong University, Jinan in 1996. He further obtained a Ph.D. from Shanghai Jiao Tong University, Shanghai, China in 2008. He has contributed his valuable publications in different scientific journals.

Mauro Salvi received his B.S. degree in Biology (1998) and Ph.D. degree in Biochemistry and Biophysics (2002) from the University of Padova, Italy. Mauro Salvi joined the faculty at the University of Padova in 1996 as Assistant Professor and was promoted to Associate Professor in 2015. His current research projects are all addressed to work out phosphorylation-based regulatory mechanisms in different signal transduction pathways studying the kinase (function, regulation, partners etc.) and the target protein substrate/s (physiological role of phosphorylation) with a combination of in silico, in vitro and in cell experimental approaches.

Dr. Anket Sharma is currently working as post-doctoral scientist at State Key Laboratory of Subtropical Silviculture, Zhejiang A&F University, China. Before joining as post- doctoral scientist, he worked as assistant professor at DAV University, Jalandhar, India. He completed his M.Phil. and Ph.D. from Guru Nanak Dev University, Amritsar, India. He was also a DST-INSPIRE Fellow from Department of Science & Technology, Government of India. He has authored 67 articles in journals and 14 chapters in books of international repute.

Professor Hubing Shi received his Ph.D. in Biochemistry and Molecular Biology from the Tsinghua University in 2007 and continued postdoctoral research at the University of California at Los Angeles from 2008-2015. He joined the State Key Laboratory of Biotherapy as professor in China in 2015. His research interests focus on discovery of the acquired resistance mechanisms in targeted therapy and development of novel combinatorial regimens with state-of-the-art treatment in clinics.

Zhaoliang Su received his PhD in Clinical Laboratory Diagnostics from the Jiangsu University. Currently, he is appointed as a Professor at Jiangsu University, China and an Executive Director of International Genome Center, Jiangsu University. He focuses on the potential mechanisms of inflammatory disorders, especially, cardiac inflammatory injury, inflammatory resolution and cardiac functional remodelling as well as cancer immune escape. Besides, he has published several articles in reputed journals.

Dr. Timothy Veenstra received his PhD in biochemistry from the University of Windsor in Canada followed by completion of a post-doctoral fellowship at the Mayo Clinic in Rochester, Minnesota. It was at the Mayo Clinic that he recognized the value of applying mass spectrometry (MS) to biomedical research. He has spent most of his career in research, utilizing MS in the fields of oncology and neurology to identify biomarkers for disease detection as well as identifying protein interactions key to disease progression. He has co-authored almost 400 peer-reviewed manuscripts and is the author of the book “Proteomic Applications in Cancer Detection and Discovery”.

Dr. Wei Wang is a Professor at the Henan Agricultural University (HAU) and a Principal Investigator of the State Laboratory of Wheat and Maize Crop Science, China. He received a PhD from the Institute of Botany, Chinese Academy of Sciences in 1995. He did his Postdoctoral studies at CSIC (Spain, 1999-2001) and University of Siena (2002-2006), where he began his work on crop genomic and proteomic works. In 2006, he moved to HAU, where he was promoted to Full Professor and then distinguished Professor in Henan province. His research focuses on maize omics and improvement. Besides, he is a member of the editorial board at Frontiers in Plant Science (Associate Editor), PLOS ONE (Academic Editor), and Acta Physiologiae Plantarum (Associate Editor).